Table 3.
Pancreatic cancer in relation to FBG levels in patients with new-onset T2DM.
| No. of cases | No. at risk | Rate/100,000 person years | Adjusted HR (95% CI)* | |
|---|---|---|---|---|
| Total | ||||
| <6·0 | 103 | 43513 | 52·70 | 1 (ref) |
| 6·0–7·9 | 572 | 270163 | 47·40 | 0·90 (0·73–1·12) |
| 8·0–9·9 | 158 | 58028 | 62·47 | 1·29 (0·99–1·66) |
| ≥10 | 107 | 23702 | 107·01 | 2·35 (1·77–3·13) |
| Male | ||||
| <6·0 | 58 | 20002 | 65·30 | 1 (ref) |
| 6·0–7·9 | 283 | 127293 | 50·43 | 0·82 (0·61–1·11) |
| 8·0–9·9 | 78 | 29332 | 62·03 | 1·13 (0·79–1·62) |
| ≥10 | 61 | 13153 | 112·36 | 2·25 (1·54–3·29) |
| Female | ||||
| <6·0 | 45 | 23511 | 42·21 | 1 (ref) |
| 6·0–7·9 | 289 | 142870 | 44·76 | 0·99 (0·72–1·37) |
| 8·0–9·9 | 80 | 28696 | 62·91 | 1·46 (1·00–2·13) |
| ≥10 | 46 | 10549 | 100·67 | 2·41 (1·56–3·72) |
*Adjusted for age, sex, BMI and SBP in all subjects and adjusted for age, BMI and SBP in males and females.